Filing Details

Accession Number:
0001209191-17-014077
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-23 20:23:32
Reporting Period:
2017-02-21
Filing Date:
2017-02-23
Accepted Time:
2017-02-23 20:23:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1513818 Versartis Inc. VSAR Pharmaceutical Preparations (2834) 264106690
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1587788 Jay Shepard C/O Versartis, Inc.
4200 Bohannon Drive, Suite 250
Menlo Park CA 94025
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-02-21 8,000 $2.53 221,858 No 4 M Direct
Common Stock Disposition 2017-02-21 8,000 $18.50 213,858 No 4 S Direct
Common Stock Acquisiton 2017-02-23 8,000 $2.53 221,858 No 4 M Direct
Common Stock Disposition 2017-02-23 8,000 $20.00 213,858 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2017-02-21 8,000 $0.00 8,000 $2.53
Common Stock Stock Option (Right to Buy) Disposition 2017-02-23 8,000 $0.00 8,000 $2.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
78,994 2023-12-27 No 4 M Direct
70,994 2023-12-27 No 4 M Direct
Footnotes
  1. Shares sold pursuant to 10b5-1 plan.
  2. 25% of the shares subject to the option become exercisable one year from 12/10/2013; the remainder become exercisable in equal monthly installments over the following three years.